NF-κB inhibits gammaherpesvirus lytic replication

Helen J. Brown, Moon Jung Song, Hongyu Deng, Ting Ting Wu, Genhong Cheng, Ren Sun

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Nasopharyngeal carcinoma, Kaposi's sarcoma, and B-cell lymphomas are human malignancies associated with gammaherpesvirus infections. Members of this virus family are characterized by their ability to establish latent infections in lymphocytes. The latent viral genome expresses very few gene products. The infected cells are therefore poorly recognized by the host immune system, allowing the virus to persist for long periods of time. We sought to identify the cell-specific factors that allow these viruses to redirect their life cycle from productive replication to latency. We find that the cellular transcription factor NF-κB can regulate this process. Epithelial cells and fibroblasts support active (lytic) gammaherpesvirus replication and have low NF-κB activity. However, overexpression of NF-κB in these cells inhibits the replication of the gammaherpesvirus murine herpesvirus 68 (MHV68). In addition, overexpression of NF-κB inhibits the activation of lytic promoters from MHV68 and human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). In lymphocytes latently infected with KSHV or EBV, the level of NF-κB activity is high, and treatment of these cells with an NF-κB inhibitor leads to lytic protein synthesis consistent with virus reactivation. These results suggest that high levels of NF-κB can inhibit gammaherpesvirus lytic replication and may therefore contribute to the establishment and maintenance of viral latency in lymphocytes. They also suggest that NF-κB may be a novel target for the disruption of virus latency and therefore the treatment of gammaherpesvirus-related malignancies.

Original languageEnglish
Pages (from-to)8532-8540
Number of pages9
JournalJournal of Virology
Volume77
Issue number15
DOIs
Publication statusPublished - 2003 Aug 1
Externally publishedYes

Fingerprint

Rhadinovirus
Virus Latency
Viruses
Human Herpesvirus 8
Lymphocytes
Human Herpesvirus 4
Aptitude
Kaposi's Sarcoma
Viral Genome
B-Cell Lymphoma
Infection
Life Cycle Stages
Immune System
Neoplasms
Transcription Factors
Fibroblasts
Epithelial Cells
Maintenance
Genes
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Brown, H. J., Song, M. J., Deng, H., Wu, T. T., Cheng, G., & Sun, R. (2003). NF-κB inhibits gammaherpesvirus lytic replication. Journal of Virology, 77(15), 8532-8540. https://doi.org/10.1128/JVI.77.15.8532-8540.2003

NF-κB inhibits gammaherpesvirus lytic replication. / Brown, Helen J.; Song, Moon Jung; Deng, Hongyu; Wu, Ting Ting; Cheng, Genhong; Sun, Ren.

In: Journal of Virology, Vol. 77, No. 15, 01.08.2003, p. 8532-8540.

Research output: Contribution to journalArticle

Brown, HJ, Song, MJ, Deng, H, Wu, TT, Cheng, G & Sun, R 2003, 'NF-κB inhibits gammaherpesvirus lytic replication', Journal of Virology, vol. 77, no. 15, pp. 8532-8540. https://doi.org/10.1128/JVI.77.15.8532-8540.2003
Brown, Helen J. ; Song, Moon Jung ; Deng, Hongyu ; Wu, Ting Ting ; Cheng, Genhong ; Sun, Ren. / NF-κB inhibits gammaherpesvirus lytic replication. In: Journal of Virology. 2003 ; Vol. 77, No. 15. pp. 8532-8540.
@article{9074598716d84b44a7b051517cf3b7e3,
title = "NF-κB inhibits gammaherpesvirus lytic replication",
abstract = "Nasopharyngeal carcinoma, Kaposi's sarcoma, and B-cell lymphomas are human malignancies associated with gammaherpesvirus infections. Members of this virus family are characterized by their ability to establish latent infections in lymphocytes. The latent viral genome expresses very few gene products. The infected cells are therefore poorly recognized by the host immune system, allowing the virus to persist for long periods of time. We sought to identify the cell-specific factors that allow these viruses to redirect their life cycle from productive replication to latency. We find that the cellular transcription factor NF-κB can regulate this process. Epithelial cells and fibroblasts support active (lytic) gammaherpesvirus replication and have low NF-κB activity. However, overexpression of NF-κB in these cells inhibits the replication of the gammaherpesvirus murine herpesvirus 68 (MHV68). In addition, overexpression of NF-κB inhibits the activation of lytic promoters from MHV68 and human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). In lymphocytes latently infected with KSHV or EBV, the level of NF-κB activity is high, and treatment of these cells with an NF-κB inhibitor leads to lytic protein synthesis consistent with virus reactivation. These results suggest that high levels of NF-κB can inhibit gammaherpesvirus lytic replication and may therefore contribute to the establishment and maintenance of viral latency in lymphocytes. They also suggest that NF-κB may be a novel target for the disruption of virus latency and therefore the treatment of gammaherpesvirus-related malignancies.",
author = "Brown, {Helen J.} and Song, {Moon Jung} and Hongyu Deng and Wu, {Ting Ting} and Genhong Cheng and Ren Sun",
year = "2003",
month = "8",
day = "1",
doi = "10.1128/JVI.77.15.8532-8540.2003",
language = "English",
volume = "77",
pages = "8532--8540",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "15",

}

TY - JOUR

T1 - NF-κB inhibits gammaherpesvirus lytic replication

AU - Brown, Helen J.

AU - Song, Moon Jung

AU - Deng, Hongyu

AU - Wu, Ting Ting

AU - Cheng, Genhong

AU - Sun, Ren

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Nasopharyngeal carcinoma, Kaposi's sarcoma, and B-cell lymphomas are human malignancies associated with gammaherpesvirus infections. Members of this virus family are characterized by their ability to establish latent infections in lymphocytes. The latent viral genome expresses very few gene products. The infected cells are therefore poorly recognized by the host immune system, allowing the virus to persist for long periods of time. We sought to identify the cell-specific factors that allow these viruses to redirect their life cycle from productive replication to latency. We find that the cellular transcription factor NF-κB can regulate this process. Epithelial cells and fibroblasts support active (lytic) gammaherpesvirus replication and have low NF-κB activity. However, overexpression of NF-κB in these cells inhibits the replication of the gammaherpesvirus murine herpesvirus 68 (MHV68). In addition, overexpression of NF-κB inhibits the activation of lytic promoters from MHV68 and human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). In lymphocytes latently infected with KSHV or EBV, the level of NF-κB activity is high, and treatment of these cells with an NF-κB inhibitor leads to lytic protein synthesis consistent with virus reactivation. These results suggest that high levels of NF-κB can inhibit gammaherpesvirus lytic replication and may therefore contribute to the establishment and maintenance of viral latency in lymphocytes. They also suggest that NF-κB may be a novel target for the disruption of virus latency and therefore the treatment of gammaherpesvirus-related malignancies.

AB - Nasopharyngeal carcinoma, Kaposi's sarcoma, and B-cell lymphomas are human malignancies associated with gammaherpesvirus infections. Members of this virus family are characterized by their ability to establish latent infections in lymphocytes. The latent viral genome expresses very few gene products. The infected cells are therefore poorly recognized by the host immune system, allowing the virus to persist for long periods of time. We sought to identify the cell-specific factors that allow these viruses to redirect their life cycle from productive replication to latency. We find that the cellular transcription factor NF-κB can regulate this process. Epithelial cells and fibroblasts support active (lytic) gammaherpesvirus replication and have low NF-κB activity. However, overexpression of NF-κB in these cells inhibits the replication of the gammaherpesvirus murine herpesvirus 68 (MHV68). In addition, overexpression of NF-κB inhibits the activation of lytic promoters from MHV68 and human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). In lymphocytes latently infected with KSHV or EBV, the level of NF-κB activity is high, and treatment of these cells with an NF-κB inhibitor leads to lytic protein synthesis consistent with virus reactivation. These results suggest that high levels of NF-κB can inhibit gammaherpesvirus lytic replication and may therefore contribute to the establishment and maintenance of viral latency in lymphocytes. They also suggest that NF-κB may be a novel target for the disruption of virus latency and therefore the treatment of gammaherpesvirus-related malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0037770173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037770173&partnerID=8YFLogxK

U2 - 10.1128/JVI.77.15.8532-8540.2003

DO - 10.1128/JVI.77.15.8532-8540.2003

M3 - Article

C2 - 12857922

AN - SCOPUS:0037770173

VL - 77

SP - 8532

EP - 8540

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 15

ER -